Tohoku J. Exp. Med., 2009, 219 (3) , 243-250. © 2009 Tohoku University Medical Press Carotid artery stenosis is frequently present in patients with coronary artery disease (CAD). Faggioli et al. (1990) documented an increased prevalence of carotid artery disease in patients requiring coronary artery bypass graft (CABG) age 60 years or older, who often had carotid artery stenosis (≥ 75%). Rath et al. (2001) presented a dissenting opinion arguing that risk factors such as hypercholesterolemia, hypertension, smoking and family history were not independent predictors of carotid artery stenosis. However, diabetes as a risk factor had a significant association with carotid artery disease. Patients with significant carotid artery stenosis had severe coronary artery disease (triple-vessel disease 93.3%, and left main CAD 12.0%). Significant internal carotid artery stenosis > 50% was found in 1.8% of CABG patients while only 1.1% had critical stenosis (> 70%) (Tarzamni et al. 2007) . Clinical predictors of significant carotid artery stenosis in CABG patients were age, diabetes, female gender, left main coronary artery stenosis ≥ 60%, prior stroke or transient ischemic attack (TIA), prior vascular operation, and smoking (D'Agostino et al. 1996) . Shichinohe et al. (2001) summarized 12 articles from the literature of [1977] [1978] [1979] [1980] [1981] [1982] [1983] [1984] [1985] [1986] [1987] [1988] [1989] [1990] , showed carotid artery stenosis was 1.3-18.9% in CABG patients, and 8.1% of their carotid artery stenosis patients had CAD necessitating a simultaneous or staged operation, including simultaneous carotid endarterectomy (CEA) and CABG, staged CEA and CABG, staged CABG and CEA, staged CEA and percutaneous transluminal coronary angioplasty (PTCA), and staged PTCA and CEA. Multivariate stepwise logistic regression revealed that age and the extent of CAD were independently related to the presence of carotid artery stenosis (Tanimoto et al. 2005) . Tanimoto et al. (2005) demonstrated that the prevalence of echographic carotid artery stenosis (echographic carotid artery stenosis as the carotid atherosclerosis with area stenosis of > 50% or peak systolic velocity of > 200 cm/s on the common carotid artery, the carotid bifurcation, and the internal carotid artery) was 7.0%, 14.5%, 21.4%, and 36.0% in patients with 0-, 1-, 2-, and 3-vessel CAD, respectively. Controversies exist concerning the surgical treatment of associated carotid artery stenosis and CAD with either a simultaneous or a staged procedure.
The aim of the present article is to compare the efficacy of different surgical approaches for associated carotid artery stenosis and CAD on basis of the literature of a recent decade.
Materials and Methods

Data Collection
A literature search of MEDLINE, EMBASE, and the Cochrane Register between 2000 and 2009 using the search terms "carotid artery stenosis" and "coronary artery disease" was made of all English language publications. Clinical studies with a patient population ≥ 6 were included. Clinical trials were collected and analyzed in terms of the patients' demographics, carotid and coronary interventional procedures, and postoperative stroke, acute myocardial infarction and mortality rates were compared between staged and simultaneous procedures.
Definitions
Patients with carotid artery occlusive disease were classified by status as symptomatic or asymptomatic. Symptomatic patients included those who had focal, transient neurologic symptoms, amaurosis fugax, or a completed stroke. Asymptomatic patients had no evidence of neurologic findings (Hamulu et al. 2001) . The hospital mortality is defined as rate of death from any cause in hospitalized populations. The late mortality represents the total number of deaths in the late stages of an ongoing treatment, or a significant length of time after an acute treatment. Stroke is a syndrome characterized by rapidly developing clinical signs of focal or global disturbance lasting 24 hours or longer or leading to death without apparent cause other than of vascular origin.
Statistics
The results were expressed as mean ± standard deviation or frequencies. The unpaired t test was used to compare means between groups, and the chi-square statistic with Yates' correction was used to compare the observed frequencies. A p value less than 0.05 was considered of statistically significant.
Results
Totally 41,901 patients undergoing simultaneous or staged carotid and coronary procedures were collected from 53 reports (Evagelopoulos et al. 2000; Snider et al. 2000; Minami et al. 2000; Gaudino et al. 2001; Hamulu et al. 2001; Youssuf et al. 2001; Estes et al. 2001; Farooq et al. 2001; Bonacchi et al. 2002; Bonardelli et al. 2002; Antunes et al. 2002; Zacharias et al. 2002; Meharwal et al. 2002; Roddy et al. 2002; Char et al. 2002; Beauford et al. 2003; Brown et al. 2003; Vitali et al. 2003; Ricotta et al. 2003; Srimahachota et al. 2004; Mishra et al. 2004; Ricotta et al. 2005; Ziada et al. 2005; Cinar et al. 2005; Eren et al. 2005; Chiappini et al. 2005; Akins et al. 2005; Nwakanma et al. 2006; Inciura and Benetis 2006; Kolh et al. 2006; Byrne et al. 2006; Cywinski et al. 2006; Kovacic et al. 2006; Mendiz et al. 2006; Randall et al. 2006; Chiariello et al. 2006; Hertzer and Mascha 2006; Madi-Jebara et al. 2006; Kougias et al. 2007; Dubinsky and Lai 2007; Zacharias et al. 2007; Türköz et al. 2007; Versaci et al. 2007; Van der Heyden et al. 2007; Abbasi et al. 2008; Balashankar et al. 2008; Bulat et al. 2008; Timaran et al. 2008; Elsharawy 2009; Palombo et al. 2009; Ranaweera et al. 2009; Iyem and Buket 2009; Versaci et al. 2009 ). Simultaneous procedures were composed of CEA plus CABG, CEA plus off-pump coronary artery bypass (OPCAB), and carotid artery stenting (CAS) plus CABG; and staged procedures were CEA plus CABG, and CAS plus CABG. Of the five procedures, simultaneous CEA and CABG was the most, and staged CEA and CABG was the next (Fig. 1) . Usually, simultaneous CEA and CABG operation was performed under general anesthesia, and only CABG was under the aid of cardiopulmonary bypass. However, some modifications were made by the surgeons, for instance, CEA was performed under local anesthesia, or both CEA and CABG were carried out under cardiopulmonary bypass.
The basic information of the simultaneous and staged procedural patients was listed in Table 1 . Staged procedures with an interval of 36.65 ± 23.11 days showed better results in terms of perioperative complications including myocardial infarction, TIA, stroke and early and late mortalities comparing to those of the simultaneous procedure (Table 2) .
Staged CAS plus CABG was associated with the highest frequency of perioperative myocardial infarction, with statistic significance comparing with simultaneous CAS and CABG of the whole patient setting. CEA plus OPCAB represented the highest incidence of perioperative myocardial infarction in the patients undergoing simultaneous procedures. The simultaneous CEA and CABG patients had more TIAs in comparison with simultaneous or staged CAS and CABG. Of the patients undergoing simultaneous procedures, CEA plus CABG resulted in more stroke events than CEA plus OPCAB or CAS plus CABG, but no signifi- cant difference was noted when comparing with the staged group. No significant differences were found in hospital mortality between simultaneous and staged procedures except for between simultaneous CEA plus CABG and simultaneous CEA plus OPCAB (Fig. 2) .
In the simultaneous group, logistic regression analysis of hospital mortality showed that a significant regression within the overall Model Fit ( p = 0.0360), and in particular, perioperative complications like TIA and stroke had even more significant relations ( p = 0.022 and p = 0.035, respectively). Perioperative stroke and TIA did not show any regression either (stroke: Chi Square = 20.0440; df=12; p = 0.0663; and TIA: Chi Square = 8.7747; df = 12; p = 0.7220). In the staged group, the hospital mortality did not have any relationship with the pre-and perioperative variables (Chi Square = 13.4602; df = 15; p = 0.5668).
Discussion
Stroke mortality is an important outcome measure in stroke epidemiology and clinical trials, defined by the World Health Organization as "the disease or injury which initiated the train of morbid events leading directly to death or the circumstances of the accident or violence which produced the fatal injury". The causes of stroke after CABG are multifactorial. There have been a lot of data which suggest that the main cause of stroke is emboli from the atherosclerotic plaques in the ascending aorta (Bonatti et al. 2006 ). Significant predictors of postoperative stroke were calcified or dilated aorta, and of prolonged hospital stay were advanced age, unstable angina, and coexisting vascular disease (Kolh et al. 2006 ). In patients with carotid artery stenosis > 80%, the incidence of stroke during CABG increases substantially from 15% to 20%, and CEA may have to be performed ahead of CABG, if both procedures are not to be done simultaneously (Gott et al. 1999) . CEA in patients with ≥ 60% stenosis reduces the risk of stroke by approximately 1% annually (Chambers and Roberts 2007) . Based on recent studies, CEA and CAS seemed to be of similar perioperative stroke risks, but CEA was associated with significantly higher incidences of local nerve injury and myo- cardial infarction (Mazighi and Abou-Chebl 2007) .
Significant multivariable predictors of in-hospital events were hospital death, perioperative stroke, perioperative myocardial infarction, and prolonged postoperative hospital stay (Akins et al. 2005) . When an isolated CEA is performed before CABG, the morbidity was relatively high up to 7-8% caused mainly by myocardial infarction (Bonacchi et al. 2002) . Meta analysis of relevant literature between 1980 and 1998 revealed a significantly increased risk of stroke or death, for patients undergoing simultaneous procedures (Borger et al. 1999) . Chiappini et al. (2005) described the hospital mortality was 6.4% in simultaneous versus 12.9% in staged procedures. By this comprehensive review, we noted that simultaneous procedure resulted in a lower mortality. However, Coyle et al. (1995) observed a higher postoperative stroke or death within 30 days in patients undergoing simultaneous procedures than those received staged operations (26.2% vs. 6.6%), which was explained as that extremely high-risk patients were selected for simultaneous procedures. Similar situations were noted by Hamulu et al. (2001) , who reported that more patients with triple-vessel coronary artery disease, left main disease and impaired left ventricular function (EF < 30%) associated with significantly higher risk factors in the simultaneous CABG and CEA group than those in the CABG alone group. Zacharias et al. (2002) reported a similar risk of perioperative stroke for both simultaneous and staged approaches, while the risks of perioperative myocardial infarction and death were significantly greater for staged procedures. Hertzer et al. (1989) compared results from combined and staged patients and found a lower stroke incidence (5.3% vs. 11.4%) and stroke/death (8.4% vs. 13.3%) with simultaneous versus staged surgery. In short, relationship of stroke to carotid artery stenosis, and the impact of prior stroke on the outcome of CABG plus CEA were undertermined (Ricotta et al. 2003) .
Patients presenting with asymptomatic carotid artery stenosis (> 70%) can undergo simultaneous CEA and CABG with low morbidity and mortality (Byrne et al. 2006) . In a multicentre trial on 1662 patients (asymptomatic carotid atherosclerosis study, ACAS) with over 60% asymptomatic carotid stenoses randomized to surgery or medical treatment, the combined stroke and mortality rate for surgery was 5.1% compared to 11% for medical treatment at a five-year follow-up (No authors listed 1995) . For symptomatic patients with internal carotid artery stenosis of 70% or more, carotid endarterectomy was superior to medical therapy alone, assuming a risk of perioperative stroke or death of less than 6%. For asymptomatic patients with stenosis exceeding 60%, carotid endarterectomy was also superior to medical therapy alone, assuming a risk of perioperative stroke or death of less than 3% (Furlan 2006) . The 30-day stroke mortality rate was 6.1% in symptomatic combined CEA plus CABG patients during the same period. This was higher than in the asymptomatic group but did not reach significance. The stroke rate for asymptomatic carotid stenoses was 1.1%, but the overall stroke mortality was 4.3% (Byrne et al. 2006 ). CEA was not recommended in the "asymptomatic"patients as the risk of stroke in patients with asymptomatic carotid disease is 2% per year and prophylactic CEA did not show any significant benefits (No authors listed 1995).
Simultaneous CEA and CABG is advantageous when compared with staged CEA and CABG or staged CAS and CABG because the patient faces only one anesthetic and surgical risk (Trachiotis and Pfister 1997) , while the staged procedure would either suspend systemic antiaggregation with an increase in neurological risk or increase surgical bleeding (Giorgetti et al. 2007 ). The carotid operation performed first without cardiopulmonary bypass, would ensure sufficient cerebral perfusion during the operation and allow for increased cerebral perfusion during cardiopulmonary bypass. In the one-stage procedure most authors repair the carotid artery stenosis before full establishment of CPB, but CPB was preferable for cerebral protection during CEA by some surgeons (Minami et al. 2000) .
Staged approach was especially indicated for the patients with severe carotid artery stenosis requiring complicated CAS. But the symptoms of CAD or carotid artery stenosis would be present during the interval, and the patients with acute onset would have to decline the stage operations, and may cause death (Antunes et al. 2002) . Six studies involving 277 patients undergoing staged CAS and CABG with mean interval between two procedures of 32 days, illustrated that the incidence of stroke and death associated with the stent procedure was 4.7%, and stroke associated with CABG was 2.2% (Guzman et al. 2008) . The minimal delay between the staged procedures and the antiplatelet regimen at the time of CABG remains an issue of debate. Antiplatelet therapy was given to the patients at the time of CAS, but it was unclear whether it should be discontinued at the time of CABG.
Conclusions
Patients with a simultaneous CEA plus CABG were generally related more to an advanced atherosclerotic CAD, so that a pure comparison between the two strategies is not always possible. To compare the efficacy of different surgical methods for the management of combined carotid and coronary arteries disease is of pronounced importance. Furthermore, the new hybrid approach consisting of simultaneous CAS and subsequent on-pump CABG can be a safe approach, with the aim to reduce the surgical trauma as compared to surgical procedures, and to reduce the risk of myocardial infarction in the interval period required in the staged operations. Thus, in patients with combined severe carotid and coronary artery disease, the staged procedure is not recommended. A simultaneous surgical approach is preferable for such patients.
